Quantifying gadolinium-based nanoparticle uptake distributions in brain metastases via magnetic resonance imaging
Abstract AGuIX, a novel gadolinium-based nanoparticle, has been deployed in a pioneering double-blinded Phase II clinical trial aiming to assess its efficacy in enhancing radiotherapy for tumor treatment. This paper moves towards this goal by analyzing AGuIX uptake patterns in 23 patients. A phantom...
Saved in:
| Main Authors: | Stephanie Bennett, Camille Verry, Evangelia Kaza, Xin Miao, Sandrine Dufort, Fabien Boux, Yannick Crémillieux, Olivier de Beaumont, Géraldine Le Duc, Ross Berbeco, Atchar Sudhyadhom |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-05-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-024-62389-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Author Correction: Quantifying gadolinium-based nanoparticle uptake distributions in brain metastases via magnetic resonance imaging
by: Stephanie Bennett, et al.
Published: (2025-03-01) -
Mechanisms of Action of AGuIX as a Pan-Cancer Nano-Radiosensitizer: A Comprehensive Review
by: Clémentine Aubrun, et al.
Published: (2025-04-01) -
Ex-vivo validation of nine algorithms for quantifying infarcts with late gadolinium enhancement cardiovascular magnetic resonance
by: Sascha Kopic, et al.
Published: (2025-01-01) -
The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review.
by: Cyprian Olchowy, et al.
Published: (2017-01-01) -
157Gd-DOTA-PSMA as theranostic bio-gadolinium agent for prostate cancer targeted gadolinium neutron capture therapy
by: Liang Xie, et al.
Published: (2025-02-01)